Interventional Radiology Market Future Development, Size, Share, COVID-19 Impact, Top Key Players, Demand and Forecast

Interventional Radiology Market research report best suits the requirements of the client. To succeed in this promptly changing marketplace, businesses must take up the market research report solution such as Interventional Radiology Market report. Strategically analyzed facts and figures of the market and keen business insights covered in this marketing report would be a key aspect in achieving enduring business growth. This market research report encompasses different industry verticals for industry such as company profile, contact details of the manufacturer, product specifications, geographical scope, production value, market structures, recent developments, revenue analysis, market shares, and possible sales volume of the company.

Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @

The key players in the market include

GE Healthcare (General Electric Company) (U.K.),

Siemens Healthcare GmBH (Siemens AG) (Germany),

Koninklijke Philips N.V. (The Netherlands),

Toshiba Medical Systems Corporation (Toshiba Corporation) (Japan),

Hitachi Medical Corporation (Hitachi Ltd.) (Japan),

Carestream Health, Inc. (U.S.),

Esaote S.p.A (Italy),

Hologic, Inc. (U.S.),

Fujifilm Corporation (Japan),

Samsung Medison (South Korea),

and Shimadzu Corporation (Japan).

On the basis of product, the market is segmented intoangiography systems, fluoroscopy systems, CT scanners, ultrasound-imaging systems, MRI system, and other devices (C-arm, contrast media injectors,& imaging catheter guidewires). The MRI system segment is estimated to account for the largest share of the market in 2016.Factors such as technological advancements and product launches are driving the growth of this segment.

Based on procedure, the market is segmented into angiography, angioplasty, embolization, thrombolysis, vertebroplasty, nephrostomy, and other procedures (biliary drainage, fallopian tube recanalization, cholecystectomy, and carotid-cavernous fistula). The angiography segment is projected to witness the highest growth in this market due to increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures.

By applications, the market is segmented into cardiology, oncology, urology & nephrology, gastroenterology, and other applications (orthopedics, neurology, and gynecology). The oncology segment is projected to witness the highest growth in this market due to increase in the incidence of cancer and rising demand for minimally invasive procedures.

Geographically, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American regionis primarily driven by the increase in the prevalence and incidence of chronic diseases and the aging population.

Research Coverage:

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies to strengthen their market shares.

The report provides insights on the following pointers:

    • Market Penetration: Comprehensive information on the product portfolios of the top players in the interventional radiology imaging market. The report analyses the interventional radiology imaging market: byproduct, by procedure, and by application.
    • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the interventional radiology imaging market
    • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional radiology imaging market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various interventional radiology imaging products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional radiology imaging market

The global interventional radiology imaging market is expected to reach USD 23.50 billion by 2021 from USD 16.99 billion in 2016, at a CAGR of 6.7%. The market is broadly classified intoproduct, procedures, and application.

Enquire Here for, Report Enquiry, Discount and Customization @

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown & Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Conclusion

4 Premium Insights
4.1 Interventional Radiology: Market Overview
4.2 Interventional Radiology Market, By Product and Region (2016)
4.3 Life Cycle Analysis, By Region

5 Industry Insights
5.1 Introduction
5.2 Porter’s Five Forces Analysis
5.2.1 Threat of New Entrants
5.2.2 Threat of Substitutes
5.2.3 Bargaining Power of Buyers
5.2.4 Bargaining Power of Suppliers
5.2.5 Intensity of Rivalry
5.3 Supply Chain Analysis
5.4 Key Influencers

6 Market Overview
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers Rising Incidence and Prevalence of Chronic Diseases Increasing Demand for Minimally Invasive Procedures Technological Advancements in Interventional Radiology Devices
6.2.2 Restraints Risk of High Radiation Exposure to Limit the Use of CT Scanners Shortage of Helium – A Major Concern for MRI Manufacturers and Healthcare Facilities
6.2.3 Opportunities Emerging Markets
6.2.4 Challenges Entry Barriers for New Players Hospital Budget Cuts Increasing Adoption of Refurbished Interventional Radiology Systems

7 Interventional Radiology Market, By Product
7.1 Introduction
7.2 MRI Systems
7.3 Ultrasound Imaging Systems
7.4 CT Scanners
7.5 Angiography Systems
7.6 Fluoroscopy Systems
7.7 Biopsy Devices
7.8 Other Devices

8 Interventional Radiology Market, By Procedure
8.1 Introduction
8.2 Angiography
8.3 Angioplasty
8.4 Biopsy and Drainage
8.5 Embolization
8.6 Thrombolysis
8.7 Vertebroplasty
8.8 Nephrostomy
8.9 Other Procedures

9 Interventional Radiology Market, By Application
9.1 Introduction
9.2 Cardiology
9.3 Urology & Nephrology
9.4 Oncology
9.5 Gastroenterology
9.6 Other Applications

10 Interventional Radiology Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Rest of Europe
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches
11.3.2 Agreements, Collaborations & Partnerships
11.3.3 Approvals
11.3.4 Expansions
11.3.5 Acquisitions
11.3.6 Other Developments

12 Company Profile
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
12.3 Siemens AG
12.4 Koninklijke Philips N.V.
12.5 Toshiba Medical Systems Corporation (Toshiba Corporation)
12.6 Hitachi Medical Corporation (Hitachi Ltd.)
12.7 Carestream Health
12.8 Esaote S.P.A.
12.9 Hologic Inc.
12.10 Shimadzu Corporation
12.11 Samsung Medison

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

Get Direct Order of this Report @

Share This Post